文献速递胃肠外科围术期管理与 ERAS

MBSAQIP数据库五年分析:结局是否在改善?

Five-Year Analysis of the MBSAQIP Database: Are We Getting Better?
PubMed 文献 · J Am Coll Surg · 2022-04-08

本研究基于MBSAQIP数据库,纳入2015至2019年接受腹腔镜Roux-en-Y胃旁路术(RYGB)和袖状胃切除术(SG)的690,770例患者,采用卡方检验和多变量泊松回归分析并发症及结局的年度变化。结果显示SG组再入院、终末器官功能障碍和全因死亡率显著相对下降,RYGB组30天再入院、ICU入住和终末器官功能障碍明显减少,但两组并发症改善情况不同。

要点

  • SG组再入院、终末器官功能障碍和全因死亡率显著下降。
  • RYGB组30天再入院、ICU入住和终末器官功能障碍明显减少。
  • RYGB组出血、术后肺炎和卒中显著减少,SG组仅出血显著减少。

核心结论

  • MBSAQIP收集数据的年份内,部分但非全部结局持续改善。
  • SG和RYGB亚组改善的结局不同,全因死亡率下降仅见于SG亚组。

研究设计与样本

  • 基于MBSAQIP注册数据库的回顾性分析,纳入2015年1月1日至2019年12月31日接受腹腔镜RYGB和SG的患者。
  • 共纳入690,770例,排除年龄小于18岁者,平均年龄44.5(±12.0)岁,平均BMI 45.2(±7.9)kg/m2,SG占73.45%。
  • 采用卡方检验评估并发症患病率年度差异,多变量泊松回归模型(对数链接和稳健估计)计算患病率比及95%CI。

主要发现

  • SG亚组再入院、终末器官功能障碍和全因死亡率从2015年至2019年显著相对下降。
  • RYGB亚组30天再入院、ICU入住和终末器官功能障碍明显减少。
  • RYGB亚组出血、术后肺炎和卒中显著减少,SG亚组仅出血显著减少。

临床怎么用

  • 应持续监测SG和RYGB的结局差异,针对不同术式优化围术期管理。
  • 关注SG组全因死亡率下降趋势,进一步探究其原因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The MBSAQIP has been used to evaluate risk and create risk models. Previous studies have determined what complications matter most. STUDY DESIGN: This study was a registry-based analysis of patients who underwent laparoscopic Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) between January 1, 2015, and December 31, 2019, at centers participating in MBSAQIP. Cases were identified using Current Procedural Terminology. Patients less than 18 years old were excluded. A chi-square test was used to assess differences in the prevalence of complications and effects across years. Using a multivariable Poisson regression model with a link log and robust estimation, prevalence ratio estimates and 95% CI were obtained. RESULTS: A total of 690,770 observations met the inclusion criteria. Mean (SD) age was 44.5 (±12.0) years, and mean (SD) BMI was 45.2 kg/m2 (±7.9). SG cases accounted for 73.45% of all observations. There was a significant relative reduction in readmissions, end-organ dysfunction, and all-cause mortality from 2015 to 2019 in the SG subgroup. There were also noticeable reductions in 30-day readmission, ICU admission, and end-organ dysfunction in the RYGB subgroup. For complications, bleeding, postoperative pneumonia, and stroke were significantly decreased in the RYGB subgroup, but only bleeding was significantly decreased in the SG subgroup during the 5-year study period. CONCLUSIONS: There has been a continuous improvement in several (but not all) outcomes through the years that the MBSAQIP has been collecting data. Different outcomes were reduced between the SG and RYGB subgroups, and the decrease in all-cause mortality was only noted in the SG subgroup.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Clapp B, Janik MR, El Badaoui J, et al. Five-Year Analysis of the MBSAQIP Database: Are We Getting Better? J Am Coll Surg. 2022. PMID: 35703820. doi:10.1097/XCS.0000000000000177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。